Meeting abstract | Open | Published:
Puromycin-sensitive aminopeptidase is involved in wild-type huntingtin clearance
Molecular Neurodegenerationvolume 7, Article number: S5 (2012)
Accumulation of neurotoxic mutated huntingtin protein (Htt) is an important contributing factor to the pathogenesis of Huntington’s disease (HD). More and more evidence has showed that wild-type Htt plays important roles in maintaining normal functions of neuronal system. The clearance of mutant Htt has been studied extensively; however, little is known about the mechanisms regulating accumulation and turnover of endogenous wild-type Htt. Puromycin-sensitive aminopeptidase (PSA) was recently identified as a major peptidase digesting TAU protein and protecting against TAU-induced neurodegeneration. PSA was also found as the peptidase responsible for digesting polyglutamine sequences released by proteasomes and removal of neurotoxic polyglutamine-expanded Htt exon-1, ataxin-3, mutant synuclein and superoxide dismutase 1 via autophagy system. These results suggest that PSA might represent a novel degradation mechanism targeting aggregate-prone neurotoxic protein substrates, including mutated Htt. However, the effects of PSA on endogenous wild-type Htt abundance remain unclear. Here, we investigated the effects of PSA on endogenous wild-type Htt clearance in vivo using a PSA overexpressing transgenic murine model and in vitro using human neuroblastoma cell line.
We first determined whether PSA regulates Htt abundance in vivo using a human PSA (hPSA) transgenic mouse model, which was generated using bacterial artificial chromosome (BAC) mediated technology. For measuring the Htt expression in hPSA transgenic mice and control mice, the brain tissues were dissected and separated, and then were homogenized by sonication followed with centrifugation at 100,000 g at 4oC. Htt in supernatants were analyzed by Western blot using anti-Htt antibodies. Immunohistochemistry was also performed using perfused brains from both hPSA and control mice according to standard protocols. And we tested whether PSA overexpression is able to reduce the abundance of endogenous Htt in human neuroblastoma cells SH-SY5Y in vitro. SH-SY5Y cells were transfected with hPSA overexpression vectors pCMV6-XL-hPSA or blank vectors and then the endogenous Htt was analyzed with Western blot and immunocytochemistry. We also investigated the effect of inhibition of PSA expression using RNA interference (Stealth-RNAi) on endogenous Htt levels in SH-SY5Y cells. Cells were transfected with siRNA oligonucleotides specific for hPSA. Efficient hPSA silencing was confirmed with both real-time RT-PCR and Western blot analysis.
In vivo studies, Western blot analysis showed that Htt is significantly decreased in human PSA transgenic mice. Immunohistochemical experiment also showed Htt expression is decreased in all the transgenic brain regions tested. In vitro studies, Western blot analysis demonstrated decrease of endogenous Htt in response to PSA overexpression and accumulation of Htt in response to PSA slicing with Stealth-RNAi in human neuroblastoma cell line SH-SY5Y. And immunocytochemistry demonstrated notable decrease and rapid accumulation of Htt in response to PSA overexpression and PSA slicing respectively in SH-SY5Y cells.
These combined in vivo and in vitro data implicate that PSA may be a key physiological regulator of clearance and turnover of wild-type Htt in neuronal system, and may play important roles in pathogenesis of HD through regulating clearance of wild-type or and mutated Htt as well.